|1.||Zheng, Haihua: 1 article (01/2013)|
|2.||Qian, Xiaobing: 1 article (01/2013)|
|3.||Huang, Zhen: 1 article (01/2013)|
|4.||Qiu, Suo: 1 article (01/2013)|
|5.||Chen, Xiaoqing: 1 article (01/2013)|
|6.||Jiang, Zhaoxin: 1 article (01/2013)|
|7.||Gao, Qianying: 1 article (01/2013)|
|8.||Meldrum, Daniel R: 1 article (12/2004)|
|9.||Meldrum, Kirstan K: 1 article (12/2004)|
|10.||Wang, Meijing: 1 article (12/2004)|
07/19/1994 - "In this report, we show that thymeleatoxin (Tx), a daphnane tumor promoter that selectively activates the phorbol ester-responsive isozymes cPKC-alpha, -beta 1, -beta 2, and -gamma, was just as effective in inducing drug resistance in KM12L4a cells as phorbol dibutyrate, a potent activator of all phorbol ester-responsive PKC isozymes. "
05/01/2001 - "In addition, the PKC activator thymeleatoxin (THX; 10(-7) M) increased pulmonary vascular resistance and compliance in a manner similar to that in hypoxia, and the L-type voltage-dependent Ca(2+) channel blocker nifedipine (10(-6) M) inhibited the response to both THX and hypoxia. "
12/01/2004 - "In separate experiments, pulmonary artery rings were treated with the PKC activator thymeleatoxin for 60 min. After hypoxia, with or without PKC inhibition, or PKC activation alone, pulmonary artery rings were subjected to mRNA analysis for TNF-alpha and IL-1beta via RT-PCR. "
|3.||Wounds and Injuries (Trauma)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Messenger RNA (mRNA)